Insider trade

Danaher Corporation (DHR)Senior Vice President - GC sold ~$1.28M

Brian W Ellis, Senior Vice President - GC at Danaher Corporation, sold ~$1.28M of Danaher Corporation shares.

~$1.28M
Approx. value · 5,700 sh @ $224.13
20K
Holds after · shares reported
Traded
Jan 30, 2025
Filed
Jan 31, 2025

The story around this disclosure

Every dated public record OQRO holds about the company from 60 days before to 120 days after, oldest first. It shows what was going on; none of it is a stated reason for the trade.

  1. Jan 15, 2025CongressDisclosed sale of DHR — reported range $1,001 - $15,000
  2. Jan 30, 2025 · this disclosureInsiderOfficer sold ~$1.28M of DHR shares in the open market

What came next

  1. Feb 7, 2025InsiderDirector sold ~$114K of DHR shares in the open market
  2. Feb 13, 2025CongressDisclosed sale of DHR — reported range $15,001 - $50,000
  3. Feb 25, 2025CongressDisclosed sale of DHR — reported range $15,001 - $50,000
  4. Feb 26, 2025CongressDisclosed partial sale of DHR — reported range $1,001 - $15,000
  5. Mar 4, 2025CongressDisclosed purchase of DHR — reported range $1,001 - $15,000
  6. Mar 5, 2025FDAFDA device clearance: Access Cortisol; DxC 500i Clinical Analyzer
  7. Mar 17, 2025FDARecall: DxC 500 AU Clinical Chemistry Analyzer, Catalog Numbers/UDI codes: C63519 / 14987666545058 C63520 / 14987666545065 Software versions: V1.3, V1.4, V1.4.1, V1.4.…
  8. Mar 20, 2025FDARecall: DxC 500 AU Clinical Chemistry Analyzer, Catalog Numbers/UDI codes: C63519 / 14987666545058 C63520 / 14987666545065. The Beckman Coulter DxC 500 AU Clinical Che…
  9. Mar 21, 2025FDARecall: Radiometer ABL90 Series - Radiometer ABL90 FLEX Model Number 393-090 Radiometer ABL90 Series - Radiometer ABL90 FLEX PLUS Model Number 393-092 The Radiometer A…
  10. Mar 27, 2025FDARecall: Beckman Coulter DxI 9000 Access Immunoassay Analyzer
  11. Mar 27, 2025CongressDisclosed sale of DHR — reported range $1,001 - $15,000
  12. Mar 28, 2025FDAFDA device clearance: Access Toxo IgG
  13. Apr 2, 2025FDARecall: HistoCore PELORIS 3, Model/Catalog Number: 45.0005/45.7512.501 A11, Software Version: 3.4.0. The HistoCore PELORIS 3 Rapid Tissue Processor is a dual retort ra…
  14. Apr 7, 2025CongressDisclosed sale of DHR — reported range $15,001 - $50,000
  15. Apr 8, 2025FDARecall: REMISOL Advance UDI-DI code: 13700962601874 All Software Versions: B92487; B92488; C24317; C28652; C37500; D04164; C44703; C57017; C69412; C69413; C73942; C739…
  16. Apr 8, 2025CongressDisclosed purchase of DHR — reported range $15,001 - $50,000
  17. Apr 11, 2025CongressDisclosed partial sale of DHR — reported range $1,001 - $15,000
  18. Apr 21, 2025CongressDisclosed sale of DHR — reported range $1,001 - $15,000
  19. Apr 23, 2025FDARecall: Apo B Reagent, REF: OSR6143
  20. Apr 23, 2025FDARecall: DxI 9000 Access Immunoassay Analyzer, Catalog Number C11137, running software version 1.20
View the official recordSEC Form 4

How to read SEC Form 4

Form 4 is the filing that officers, directors and owners of more than 10% of a US-listed company must send to the SEC within two business days after they buy, sell or otherwise change their holding of the company's stock.

Full guide: What is an SEC Form 4?

What else is on file for Danaher Corporation

For Danaher Corporation, OQRO holds 3 insider filings (SEC Form 4 or Form 144), 3 Congress trade reports and 86 fund holdings reports (13F) dated in the last 90 days.

These are records OQRO holds, counted by their date, not a measure of how much trading took place. Routine paperwork such as option exercises and tax withholding is left out. Everything for the company is on its DHR page.

Other recent filings by Brian W Ellis, Senior Vice President - GC

The full history of Brian W Ellis, Senior Vice President - GC is on the profile page.

How this filing works

Other disclosures at Danaher Corporation

Everything OQRO holds on this company is on its DHR page.

This is one filing. OQRO holds the rest

Insider trades filed with the SEC, stock trades disclosed by members of Congress, fund holdings from 13F filings and federal contract awards, each one in plain words next to its official filing. On this page it opens why the trade stands out, what the company did around that time, the price since, and every field of the form.

OQRO Pro is a paid subscription. You see the price before you pay

OQRO describes public disclosures and context calculated from them. It does not give personalized advice and does not recommend any transaction. How OQRO treats data